Clinical Trial Update: Zonisamide for Heavy Drinkers With Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating zonisamide for heavy drinking in individuals with bipolar disorder was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorders
• Bipolar Disorder

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorders, Bipolar Disorder | Phase 2 | Status: TERMINATED | Results posted: 2016-04-22